Cutting edge: Highly alloreactive dual TCR T cells play a dominant role in graft-versus-host disease.
about
Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cellsStructural Basis for T Cell Alloreactivity among Three HLA-B14 and HLA-B27 AntigensThe CD8 T-cell response during tolerance induction in liver transplantationMemory T-cell-specific therapeutics in organ transplantation.Viral infection triggers central nervous system autoimmunity via activation of CD8+ T cells expressing dual TCRs.The ability to rearrange dual TCRs enhances positive selection, leading to increased Allo- and Autoreactive T cell repertoires.Antigen-inexperienced memory CD8+ T cells: where they come from and why we need them.Alloreactivity is limited by the endogenous peptide repertoireAllelic exclusion of TCR α-chains upon severe restriction of Vα repertoireOn the logic of restrictive recognition of peptide by the T-cell antigen receptor.Bi-Allelic TCRα or β Recombination Enhances T Cell Development but Is Dispensable for Antigen Responses and Experimental Autoimmune Encephalomyelitis.Heterogeneity within T Cell Memory: Implications for Transplant ToleranceThe highly alloreactive nature of dual TCR T cellsLow-Affinity Memory CD8+ T Cells Mediate Robust Heterologous Immunity.Dual receptor T cells mediate pathologic alloreactivity in patients with acute graft-versus-host diseaseA novel anti-IL4Rα nanoparticle efficiently controls lung inflammation during asthmaAlloimmune response results in expansion of autoreactive donor CD4+ T cells in transplants that can mediate chronic graft-versus-host diseaseMolecular mimicry as a mechanism of autoimmune disease.A stepwise model of polyreactivity of the T cell antigen-receptor (TCR): its impact on the self-nonself discrimination and on related observations (receptor editing, anergy, dual receptor cells).A New Window into the Human Alloresponse.IL-4: an important cytokine in determining the fate of T cells.One is better than two: TCR pairing and GVHD.Proinflammatory Dual Receptor T Cells in Chronic Graft-versus-Host Disease.Alloimmune T cells in transplantation.
P2860
Q26851647-C883A8BD-70DD-4767-91BF-1F8E3EF8C324Q27646543-15554270-A12C-42AC-8B20-705145FB145AQ28079184-DCB2E658-6D3C-47D4-89EE-595AADDBFDE2Q33708195-A213351D-3814-4A9C-BF51-84A76B7C428BQ33976170-4FD77A32-E245-4E1F-9163-DF63F77ED057Q33992446-C28A90BE-595C-42AD-8E37-E46C6309CC61Q34556329-56928FA4-923F-4A4D-87B9-2147C11602BAQ34621287-7263BEB5-804C-47B5-A0DD-EB89C0BAEEC9Q34689512-B97EDE5B-FF44-4F7B-AFA6-3D6522595FBFQ34899954-23CD1F45-19DC-4C63-AC6B-DB237EFA87BDQ35875258-C9D96E83-3ADB-4B19-9988-7A86D72067CEQ35927610-C477AE7B-816A-4535-AAD2-87198817CC8BQ36431046-C0201359-F348-41AE-B464-AED11C1B9D81Q36655788-A5129956-D807-4E53-9B23-C61419513846Q37383856-6EBEA159-04C5-4F9C-AA31-293B1E5DC839Q37399405-49E099E3-3839-4101-8912-F6A1DE27E900Q37479204-1C4A3848-6B95-4C35-81F1-EBF1776DD77FQ37957762-62A37EA4-EDE2-4862-82DC-9AC1031BAAECQ38171305-0F4150DE-65A1-4029-AC14-F4BB31DA4BE3Q38694588-66F1EC90-17A0-4878-A2A8-C981597A026DQ39310085-FB09DA4C-C3E1-4472-82A0-56759FE767A3Q43559416-49DB26D6-8171-4E70-A6CE-5544C556267CQ46974561-1C089159-ACBA-4034-8B94-33BD7BFFAC4DQ50936985-1A01D8C9-4D81-4568-A577-5295AFAF8C5C
P2860
Cutting edge: Highly alloreactive dual TCR T cells play a dominant role in graft-versus-host disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cutting edge: Highly alloreact ...... in graft-versus-host disease.
@ast
Cutting edge: Highly alloreact ...... in graft-versus-host disease.
@en
Cutting edge: Highly alloreact ...... in graft-versus-host disease.
@nl
type
label
Cutting edge: Highly alloreact ...... in graft-versus-host disease.
@ast
Cutting edge: Highly alloreact ...... in graft-versus-host disease.
@en
Cutting edge: Highly alloreact ...... in graft-versus-host disease.
@nl
prefLabel
Cutting edge: Highly alloreact ...... in graft-versus-host disease.
@ast
Cutting edge: Highly alloreact ...... in graft-versus-host disease.
@en
Cutting edge: Highly alloreact ...... in graft-versus-host disease.
@nl
P2860
P356
P1476
Cutting edge: Highly alloreact ...... in graft-versus-host disease.
@en
P2093
Gerald P Morris
Paul M Allen
P2860
P304
P356
10.4049/JIMMUNOL.0900638
P407
P577
2009-06-01T00:00:00Z